A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer

Overview of attention for article published in Clinical Cancer Research, March 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 8,479 followers.

A phase 1 trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with… https://t.co/8Yn78TrIry #breastcancer

A phase 1 trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen recept https://t.co/v5vDj3z6qX

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.